A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy Participants

Clinical trial NCT07341152 · COMPLETED

Trial details

NCT number: NCT07341152
Sponsor: Latigo Biotherapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pain Management

Start date: 2025-10-06
Primary completion: 2025-11-17
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.